139 related articles for article (PubMed ID: 3512113)
1. Treatment of advanced neuroblastoma with high-dose melphalan and autologous bone marrow transplantation.
Hartmann O; Kalifa C; Benhamou E; Patte C; Flamant F; Jullien C; Beaujean F; Lemerle J
Cancer Chemother Pharmacol; 1986; 16(2):165-9. PubMed ID: 3512113
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
Valteau-Couanet D; Vassal G; Pondarré C; Bonnay M; Benhamou E; Couanet D; Plantaz D; Hartmann O
Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343
[TBL] [Abstract][Full Text] [Related]
3. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma.
Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
J Clin Oncol; 1987 Aug; 5(8):1205-11. PubMed ID: 3305792
[TBL] [Abstract][Full Text] [Related]
4. High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma.
Pritchard J; McElwain TJ; Graham-Pole J
Br J Cancer; 1982 Jan; 45(1):86-94. PubMed ID: 7037033
[TBL] [Abstract][Full Text] [Related]
5. High dose melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group.
Pritchard J; Cotterill SJ; Germond SM; Imeson J; de Kraker J; Jones DR
Pediatr Blood Cancer; 2005 Apr; 44(4):348-57. PubMed ID: 15546135
[TBL] [Abstract][Full Text] [Related]
6. High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma.
Cunningham D; Paz-Ares L; Milan S; Powles R; Nicolson M; Hickish T; Selby P; Treleavan J; Viner C; Malpas J
J Clin Oncol; 1994 Apr; 12(4):759-63. PubMed ID: 8151319
[TBL] [Abstract][Full Text] [Related]
7. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer.
Lazarus HM; Herzig RH; Graham-Pole J; Wolff SN; Phillips GL; Strandjord S; Hurd D; Forman W; Gordon EM; Coccia P
J Clin Oncol; 1983 Jun; 1(6):359-67. PubMed ID: 6366139
[TBL] [Abstract][Full Text] [Related]
8. [Metastatic neuroblastoma: consolidation treatment with 2 courses of high-dose chemotherapy followed by a bone marrow autograft].
Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
Bull Cancer; 1988; 75(1):119-23. PubMed ID: 3282574
[TBL] [Abstract][Full Text] [Related]
9. High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastoma.
Kushner BH; Gulati SC; Kwon JH; O'Reilly RJ; Exelby PR; Cheung NK
Cancer; 1991 Jul; 68(2):242-7. PubMed ID: 1906368
[TBL] [Abstract][Full Text] [Related]
10. [Total body irradiation, vincristine in continuous infusion and high-dose melphalan with transplant of autologous bone marrow in the treatment of neuroblastoma].
Dini G; Garaventa A; Lanino E; Perin GP; Scarpati D; Viscoli C; Franchini E; Corvò R; Dallorso S; Cinollo G
Pediatr Med Chir; 1987; 9(1):1-7. PubMed ID: 3306621
[TBL] [Abstract][Full Text] [Related]
11. [High-dose chemoradiotherapy with bone marrow transplantation as a consolidation treatment of neuroblastoma. Results in 49 unselected patients with stage IV cancer and older than 1 year. Report of the LMCE neuroblastoma group].
Kremens B; Philip T; Bernard JL; Zucker JM
Klin Padiatr; 1987; 199(3):218-23. PubMed ID: 3306132
[TBL] [Abstract][Full Text] [Related]
12. Late intensification with high-dose melphalan and autologous bone marrow support in breast cancer patients responding to conventional chemotherapy.
Vincent MD; Powles TJ; Coombes RC; McElwain TJ
Cancer Chemother Pharmacol; 1988; 21(3):255-60. PubMed ID: 3282709
[TBL] [Abstract][Full Text] [Related]
13. High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study.
Pole JG; Casper J; Elfenbein G; Gee A; Gross S; Janssen W; Koch P; Marcus R; Pick T; Shuster J
J Clin Oncol; 1991 Jan; 9(1):152-8. PubMed ID: 1985165
[TBL] [Abstract][Full Text] [Related]
14. High-dose melphalan, vincristine, and total-body irradiation with autologous bone marrow transplantation in children with relapsed neuroblastoma: a phase II study.
Pinkerton CR; Philip T; Biron P; Frapazz D; Phillipe N; Zucker JM; Bernard JL; Philip I; Kemshead J; Favrot M
Med Pediatr Oncol; 1987; 15(5):236-40. PubMed ID: 3309605
[TBL] [Abstract][Full Text] [Related]
15. Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation Group.
Bonetti F; Zecca M; Pession A; Messina C; Montagna D; Lanino E; Fagioli F; Santoro N; Prete A; Cesaro S; Rondelli R; Giorgiani G; De Stefano P; Locatelli F
J Clin Oncol; 1999 Dec; 17(12):3729-35. PubMed ID: 10577844
[TBL] [Abstract][Full Text] [Related]
16. Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma.
Gordon SJ; Pearson AD; Reid MM; Craft AW
Eur J Cancer; 1992; 28A(8-9):1319-23. PubMed ID: 1515242
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of high-dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastoma.
Corbett R; Pinkerton R; Pritchard J; Meller S; Lewis I; Kingston J; McElwain T
Eur J Cancer; 1992; 28A(8-9):1324-8. PubMed ID: 1515243
[TBL] [Abstract][Full Text] [Related]
18. Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs.
Martino M; Postorino M; Gallo GA; Messina G; Neri S; Piro E; Gentile M; Moscato T; Monteleone R; Fedele R; Mazzone C; Console G; Penna G; Alati C; Vincelli ID; Irrera G; Musolino C; Ronco F; Molica S; Morabito F
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):148-54. PubMed ID: 24417912
[TBL] [Abstract][Full Text] [Related]
19. Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation.
McCowage GB; Vowels MR; Shaw PJ; Lockwood L; Mameghan H
J Clin Oncol; 1995 Nov; 13(11):2789-95. PubMed ID: 7595740
[TBL] [Abstract][Full Text] [Related]
20. High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma.
Graham-Pole J; Lazarus HM; Herzig RH; Gross S; Coccia P; Weiner R; Strandjord S
Am J Pediatr Hematol Oncol; 1984; 6(1):17-26. PubMed ID: 6370012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
